BIO-key International, Inc. provided revenue guidance for the full year 2022. For the year, the company expects revenue of $10 million to $13 million. Approximately 70% of the lower end of this guidance range relates to contracted recurring software license revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -3.05% | -6.47% | -47.00% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.00% | 2.88M | |
-28.45% | 1.48B | |
+195.70% | 161M | |
+15.11% | 120M | |
+18.87% | 81.29M | |
-28.62% | 50.17M |
- Stock Market
- Equities
- BKYI Stock
- News BIO-key International, Inc.
- BIO-key International, Inc. Provides Revenue Guidance for the Full Year 2022